These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38563128)
1. New knowledge on anti-IgLON5 disease. Gaig C; Sabater L Curr Opin Neurol; 2024 Jun; 37(3):316-321. PubMed ID: 38563128 [TBL] [Abstract][Full Text] [Related]
2. Ocular Motor Abnormalities in Anti-IgLON5 Disease. Macher S; Milenkovic I; Zrzavy T; Höftberger R; Seidel S; Berger-Sieczkowski E; Berger T; Rommer PS; Wiest G Front Immunol; 2021; 12():753856. PubMed ID: 34659261 [TBL] [Abstract][Full Text] [Related]
3. Hypothalamic-Bulbar MRI Hyperintensity in Anti-IgLON5 Disease with Serum-Restricted Antibodies: A Case Report and Systematic Review of Literature. Tagliapietra M; Frasson E; Cardellini D; Mariotto S; Ferrari S; Zanusso G; Plebani M; Monaco S J Alzheimers Dis; 2021; 79(2):683-691. PubMed ID: 33337376 [TBL] [Abstract][Full Text] [Related]
13. Neurodegeneration Induced by Anti-IgLON5 Antibodies Studied in Induced Pluripotent Stem Cell-Derived Human Neurons. Ryding M; Gamre M; Nissen MS; Nilsson AC; Okarmus J; Poulsen AAE; Meyer M; Blaabjerg M Cells; 2021 Apr; 10(4):. PubMed ID: 33917676 [TBL] [Abstract][Full Text] [Related]
14. Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy. Erro ME; Sabater L; Martínez L; Herrera M; Ostolaza A; García de Gurtubay I; Tuñón T; Graus F; Gelpi E Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31826985 [TBL] [Abstract][Full Text] [Related]
16. Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy. Cagnin A; Mariotto S; Fiorini M; Gaule M; Bonetto N; Tagliapietra M; Buratti E; Zanusso G; Ferrari S; Monaco S J Alzheimers Dis; 2017; 59(1):13-20. PubMed ID: 28550263 [TBL] [Abstract][Full Text] [Related]
17. HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease. Gaig C; Ercilla G; Daura X; Ezquerra M; Fernández-Santiago R; Palou E; Sabater L; Höftberger R; Heidbreder A; Högl B; Iranzo A; Santamaria J; Dalmau J; Graus F Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31454761 [TBL] [Abstract][Full Text] [Related]
18. Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease: A Case Series. Strippel C; Heidbreder A; Schulte-Mecklenbeck A; Korn L; Warnecke T; Melzer N; Wiendl H; Pawlowski M; Gross CC; Kovac S Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35031586 [TBL] [Abstract][Full Text] [Related]
19. Anti-IgLON5 disease with distinctive brain MRI findings responding to immunotherapy: A case report. Pi Y; Zhang LL; Li JC Medicine (Baltimore); 2021 Jan; 100(4):e24384. PubMed ID: 33530233 [TBL] [Abstract][Full Text] [Related]
20. HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 disease. Koneczny I; Macher S; Hutterer M; Seifert-Held T; Berger-Sieczkowski E; Blaabjerg M; Breu M; Dreyhaupt J; Dutra LA; Erdler M; Fae I; Fischer G; Frommlet F; Heidbreder A; Högl B; Klose V; Klotz S; Liendl H; Nissen MS; Rahimi J; Reinecke R; Ricken G; Stefani A; Süße M; Teive HAG; Weis S; Berger T; Sabater L; Gaig C; Lewerenz J; Höftberger R Front Immunol; 2024; 15():1376456. PubMed ID: 38827736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]